Antibody contract manufacturing market is projected to reach USD 17 billion by 2030, claims Roots Analysis

4
health-fitness

Summary

The antibody contract manufacturing market is currently dominated by the presence of small and mid-sized companies

Press Release

With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone

Roots Analysis has announced the addition of the “Antibody Contract Manufacturing Market, 2020-2030” report to its list of offerings.

Although biopharmaceuticals offer significant profit margins and have been proven to be effective in treating a myriad of diseases, they are generally associated with high costs of development and complex manufacturing protocols; this is true for antibody-based products as well. Presently, there are a number of companies that claim to offer end-to-end solutions, ranging from antibody development to commercial production. Further, prevalent trends suggest that sponsor companies are likely to continue relying on contract service providers for various aspects of antibody-based product development and manufacturing.

To order this 285+ page report, which features 100+ figures and 110+ tables, please visit this

https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html

Key Market Insights

Over 100 CMOs presently claim to offer manufacturing services for antibodies

The antibody contract manufacturing market is currently dominated by the presence of small and mid-sized companies, which represent 70% of the industry stakeholders. It is also worth highlighting that more than 55% of CMOs claim to have the capabilities to manufacture antibodies across all scales of operation (preclinical, clinical and commercial).

More than 90% service providers are focused on the production of monoclonal antibodies

However, players based in Asia are now increasingly focusing on the development of bispecific antibodies for therapeutic use. It worth highlighting that close to 20% of the CMOs engaged in this domain claim to offer manufacturing services for both bispecific antibodies and antibody fragments.

To request a sample copy / brochure of this report, please visit this – https://www.rootsanalysis.com/reports/295/request-sample.html

For additional details, please visit

https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html or email [email protected]

You may also be interested in the following titles:

  1. Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030
  2. Antibody Drug Conjugates (ADCs) – Linker and Conjugation Technologies Market, 2019-2030
  3. Antibody Drug Conjugates Market (5th Edition), 2019-2030

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]

Facebook – https://www.facebook.com/RootsAnalysis

LinkedIn – https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter – https://twitter.com/RootsAnalysis